HYALURONIC ACID IN THE TREATMENT OF OSTEOARTHRITIS

Download full text PDF
Issue: 
2
Year: 
2015

E. Yashina, Candidate of Medical Sciences

The introduction of the hyaluronic acid is still considered as a qualitative breakthrough in the treatment of patients with osteoarthritis (OA). In order to obtain primary information to assess the market potential of hyaluronan in Russia in 20 centers in 18 cities conducted in-depth interviews with medical professionals as well as patients with OA. The data reveal a large potential market hyaluronic acid in Russia, which manifests itself as a high level of training, and a good response in patients with OA treatment. Proven efficacy and safety, as well as the diversity of the positive ef-fect is the basis for the widespread use of these drugs in OA for intraarticular injection as Suplazin and Suplazin 1-SHOT (Вioniche teoranta Co., Ireland).
Keywords: 
osteoarthritis
hyaluronicacid
Suplazin

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Adatia A., Rainsford K., Kean W. Osteoarthritis of the knee and hip. Part I: aetiology and pathogenesis as a basis for pharmacotherapy // J. Pharm. Pharmacol. – 2012; 64 (5): 617–25.
  2. EULAR Compendium on Rheumatic Disease. Ed. JWJ Bijsma // BMJ. – 2009; 2. 824 r.
  3. Nasonova V.A., Mendel' O.I., Denisov L.N. i dr. Osteoartroz i ozhirenie: kliniko-patogeneticheskie vzaimosvjazi // Profilakticheskaja medi-tsina. – 2011; 1: 29–37.
  4. Hochberg M., Altman R., April K. et al. ACR 2012 recommendations for the use of nonfarmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee // Arthritis Care Res. (Hoboken). – 2012; 64: 465–74.
  5. Barrett J., Siviero P. Retrospective study of outcomes in Hyalgan treated patients with osteoarthritis of the knee // Clin. Drug. Invest. – 2002; 22: 87–97.
  6. Marshall K. Intra-articular hyaluronan therapy // Foot Ankle Clin. N. Am. – 6. 2003; 8 (2): 221–32.
  7. Schumacher H., Meador R., Sieck M. et al. Pilot investigation of hyaluronate 7. injections for first metacarpalcarpal osteoarthritis // J. Clin. Rheumatol. – 2004; 10 (2): 59–62.
  8. Silverstein E., Leger R., Shea K. The use of intra-articular hylan G-F 20 in the treat-ment of symptomaticosteoarthritis of the shoulder: a preliminary study // Am. J. Sports. Med. – 2007; 35 (6): 979–85.
  9. Maheu E., Hatimi J., Ravaud P. Intra-arthicular treatment for osteoarthritis for the knee: a French survey on use habits and perceptions by rheumatologists. Abstr. Ann. EULAR Congress. Berlin, 2004; 364.
  10. Suschuk E.A. Otsenka effektivnosti preparatov gialuronovoj kisloty v lechenii osteoartrita s pozitsij dokazatel'noj meditsiny [elektronnyj resurs] / M., 2007; rezhim dostupa: http://www.go-on.rotta.ru
  11. Hamburger M., Lakhanpal S., Mooar P. et al. Intra-articular hyaluronans: a re-view of product-specific safety profiles // Semin. Arthritis Rheum. – 2003; 32 (5): 296–309.
  12. Gosh P., Guidolin D. Potential Mechanism of Action of Intra-articular Hyaluronan Therapy in Osteoarthritis: Are the Effects Moleculasr Weight Dependent? // Semin. Arthritis Rheum. – 2002; 32 (1): 10–37.
  13. Strahov M.A., Skorogljadov A.V. Sovremennye tendentsii ispol'zova nija sredstv, zameschajuschih sinovial'nuju zhidkost', na osnove svjazannoj gialuronovoj kisloty v lechenii patsientov s travmami i zabolevanijami opornodvigatel'nogo apparata // Vestn. travmatol. i ortoped. im. N.N. Priorova. – 2013; 4: 2–7
  14. Moreland L. Intra-articular hyaluronan (hyaluronic acid) and hylans for the trearment of osteoarthritis: mechanisms of actions // Arthritis Res. Ther. – 2003; 5: 54–67.
  15. Gydek A. et al. Efficacy and safety of intra-articular use of Hyaluronic acid (Suplasyn) in the treatment of knee osteoarthritis // Przegl. Lek. – 2011; 68 (6): 307–10.
  16. Blanch-Rubiò J., Badstübner R., Schnee B. et al. ASKOT study: Effectiveness and safety of a 1-shot injection of sodium Hyaluronate for knee osteoarthritis treatment [elektronnyjresurs] / Springer Experience & Drug Evidence – rezhim dostupa: http://www.orthops.si/documents/suplasyn-askot_2012_blanch.pdf
  17. Chevalier X. et al. Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with simptomatic primary osteoarthritis of the knee: a randomised, multicentre, double-blind, placebo contolled trial // Ann. Rheum. Dis. – 2010; 69: 113–9.